DermaSensor

Name: DermaSensor
Address: Miami, FL, 33130, US
Telephone: +18553736767

America’s first FDA-cleared, AI-powered skin cancer detection device. Clinically proven and trusted by Primary Care Physicians.

DermaSensor is designing an affordable handheld sensor that will be able to evaluate skin for potential cancer in seconds. Results will be displayed instantly. Our device will use machine learning algorithms, a type of artificial intelligence, to more accurately assess potential skin cancer.

06/19/2026

The way providers evaluate suspicious skin lesions is evolving.

DermaSensor™ was designed to bring AI-powered, non-invasive skin cancer risk assessment into real-world clinical workflows, helping support faster, more objective evaluations during the patient visit.

Backed by clinical evidence, built for everyday practice, and designed to fit naturally into modern healthcare settings.

See why more providers are exploring DermaSensor™ and request a demo at dermasensor.com.

06/18/2026

Award-winning innovation is only meaningful when it creates real impact in clinical practice.

From recognition by TIME, SXSW, Inc., and The Digital Health Hub Foundation to real-world use in patient care, DermaSensor™ continues to help support the future of skin cancer assessments with AI-powered, non-invasive technology.

Designed for modern healthcare workflows. Built to support more confident clinical evaluations at the point of care.

Learn more about integrating DermaSensor™ into your practice at dermasensor.com.

06/17/2026

A tan may be trending, but so is the risk that comes with it.

While indoor tanning has declined, outdoor tanning is making a comeback. In fact, online searches for "tanning" have increased 30% year over year.

At the same time, melanoma rates continue to rise. Women under 50 are more likely to develop melanoma than any cancer except breast and thyroid cancer, and melanoma cases are expected to increase again this year.

The conversation shouldn't just be about getting a tan. It should also be about protecting your skin, understanding your risk, and prioritizing early detection.

☀️ Wear sunscreen.
🔎 Monitor changes in your skin.
📅 Don't skip regular skin checks.

Looking for a skin cancer assessment? Visit our website to find a DermaSensor provider near you.

06/15/2026

Primary care physicians are often the first clinicians patients turn to when they notice a suspicious skin lesion.

That’s why DermaSensor™ is focused on bringing innovative, AI-powered technology into everyday clinical practice to help support earlier skin cancer assessments and more informed evaluations at the point of care.

Chief Commercial Officer Carolyn Walsh shares how DermaSensor™ is working to help improve skin cancer care by supporting the providers on the front lines of patient care. 🔬

Looking to enhance skin cancer assessment in your practice? Learn more about DermaSensor™ at dermasensor.com.

06/10/2026

A major milestone for DermaSensor. 🌍

With the Class IIb CE Mark and an active collaboration with the NHS, DermaSensor is taking an important step toward expanding access to AI-powered skin cancer detection across Europe.

As we continue our global expansion, we're committed to helping healthcare providers assess suspicious skin lesions with greater confidence through non-invasive, real-time technology.

🔗 Read the full announcement using the link below.

https://www.dermasensor.com/resource/dermasensor-announces-class-iib-ce-mark-and-collaboration-with-nhs-marking-the-beginning-of-its-global-expansion/

06/08/2026

Hear directly from Dr. Joseph Gomes about DermaSensor™ and the fantastic addition it has been to his practice.

From supporting real-time clinical decision-making to helping enhance patient care workflows, providers are seeing firsthand how AI-powered, non-invasive technology can support skin cancer assessments at the point of care.

If you want to learn more about the device, its benefits, and how it can support your practice, visit dermasensor.com.

06/05/2026

Healthcare providers evaluate suspicious skin lesions every single day.

DermaSensor™ was built to bring timely, objective skin cancer risk assessment support directly to the point of care using AI-powered, non-invasive technology.

Designed for real clinical environments. Built to support more confident clinical decision-making.

Learn more about DermaSensor™ at dermasensor.com.

06/03/2026

What started as a question in 2009 became a mission to change how suspicious skin lesions are evaluated. 🔬

DermaSensor™ CEO and Co-Founder Cody Simmons shares the story behind the company, from early spectroscopy research and proof-of-concept studies to developing a handheld AI-powered device designed for real-world clinical care.

The vision was simple but ambitious: create technology that could help make skin cancer assessments faster, more accessible, and non-invasive at the point of care.

Today, DermaSensor™ is helping providers bring more confidence and support into skin cancer evaluations. 🚀

Learn more about the technology behind DermaSensor™ at dermasensor.com.

06/01/2026

Summer means more UV exposure ☀️ and more reasons to stay proactive about your skin health.

Most skin cancers are linked to UV exposure, which is why regular skin checks matter just as much as daily sunscreen.

DermaSensor™ helps support providers with AI-powered, non-invasive technology designed to assist in evaluating suspicious skin lesions in real time.

Patients: schedule your summer skin check.
Providers: bring smarter skin assessments into your workflow.

Learn more at dermasensor.com.

Address

Miami, FL
33130

Telephone

+18553736767

Website

https://www.dermasensor.com/

Alerts

Be the first to know and let us send you an email when DermaSensor posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to DermaSensor:

Shortcuts

Want your business to be the top-listed Equipment Service in Miami?